Details of the Drug

General Information of Drug (ID: DMT6H3J)

Drug Name

AbGn-168

Synonyms

AbGn-168H; Antibody 168 (autoimmune diseases), Boehringer Ingelheim/AbGenomics; Anti-CD162 mAb (psoriasis), Boehringer/AbGenomics

Indication

Disease Entry	ICD 11	Status	REF
Allergy	4A80-4A85	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
P-selectin glycoprotein ligand 1 (SELPLG)	TTS5K8U	SELPL_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT01855880) Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Avarx.